infliximab FDA Link

a chimeric monoclonal antibody to TNFalpha for the treatment of Crohn's disease & rheumatoid arthritis

Also Known As:

Remicade; Centocor brand of infliximab; Essex brand of infliximab; MAb cA2; Schering brand of infliximab; Schering-Plough brand of infliximab; monoclonal antibody cA2

Pharmalogical Action Categories:

Anti-Inflammatory Agents
Dermatologic Agents
Gastrointestinal Agents
Antirheumatic Agents

-

Amino Acids, Peptides, and Proteins

-

Proteins: 58433

-

Blood Proteins: 3862

-

Serum Globulins: 74

-

Immunoglobulins: 20136

-

Antibodies: 77322

-

Monoclonal Antibodies: 16025

*

infliximab: 3108

-

Immunoproteins: 30

-

Immunoglobulins: 20136

-

Antibodies: 77322

-

Monoclonal Antibodies: 16025

*

infliximab: 3108

-

Globulins: 305

-

Serum Globulins: 74

-

Immunoglobulins: 20136

-

Antibodies: 77322

-

Monoclonal Antibodies: 16025

*

infliximab: 3108

Rozsa Schlenker-Herceg Selected Research

Articles by Research Topic

Disease

Drug/Important Bio-Agent (IBA)